The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

What’s Going Around: Breathing problems, allergies, RSV, outdoor injuries Wayne County Breathing problems, asthma & allergies, dehydration, stomach viruses, RSV, outdoor injuries.

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

Please provide your email address to receive an email when new articles are posted on . The FDA approved the monoclonal antibody clesrovimab-cfor for preventing RSV disease in babies. Unlike ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

The FDA has blessed Merck’s Enflonsia to prevent RSV in infants. The shot will challenge Sanofi and AstraZeneca’s blockbuster Beyfortus.

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season ...

An antibody treatment for respiratory syncytial virus (RSV) appears to be more effective at protecting infants from severe illness than vaccination during pregnancy.

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all their hospitalizations. However, a study published in Morbidity and Mortality ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the importance of timely vaccination and nirsevimab administration.

New RSV vaccine, treatment linked to dramatic fall in baby hospitalizations CDC study finds big declines in hospitalizations—and they may be underestimates.